✨ SAVE 10% WITH CODE: WELCOME10 • FREE GHK-CU 100MG ON ORDERS $300+

⚠️ FOR LABORATORY & RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

GLP-2 (TZ)

Price range: $90.00 through $170.50

Vial Quantity Discounts

Quantity Price / Vial Savings
1-2 vials — —
3-4 vials — 10% off
5-9 vials — 15% off

Tirzepatide (Dual GIP/GLP-1 Analogue) 

CAS Number: 2023788-19-2
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.52 g/mol
Synonyms: LY3298176, GIP/GLP-1 receptor dual agonist

Description:
Tirzepatide is a synthetic peptide designed to mimic the biological activity of both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. In in vitro environments, it is often investigated for its dual receptor activity and potential implications in studies involving energy balance, glucose metabolism, and receptor signaling cascades. Its unique structure allows researchers to explore synergistic effects in metabolic research.

Form: Lyophilized powder
Purity: ≥98% (HPLC)
Storage: Store at -20°C. Protect from light and moisture.
Solubility: Soluble in sterile water, DMSO, or appropriate buffer.

Applications:
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic purposes.

Disclaimer:
All products sold by SP Biolabs are intended for laboratory research use only. Not for human or veterinary use. Not for diagnostic, therapeutic, or cosmetic purposes. By purchasing, you confirm that you are a qualified professional or entity using these materials for lawful scientific research only.

Amount

10mg, 20 mg

🔬 MOLECULAR PROFILE

What Is GLP-2 (TZ)?

TypeSynthetic dual GIP/GLP-1 receptor agonist peptide
CAS Number2023788-19-2
Molecular Weight4,813.45 g/mol
Amino Acids39 amino acids
Fatty Acid ChainC20 fatty diacid
🔗 PubChem Database
🧊 STORAGE REQUIREMENTS

Stability Information

Avoid freeze/thaw cycles Protect from light Keep refrigerated Keep frozen
❄️
Lyophilized (powder)
-20°C (preferred) · 24+ months
💧
Reconstituted
2–8°C

📚 Sources & References

Peer-reviewed research

GUIDE TO PHARMACOLOGY (IUPHAR/BPS)
Tirzepatide
2026 · IUPHAR/BPS
View Source ↗
NATURE COMMUNICATIONS
Structural insights into multiplexed pharmacological actions of tirzepatide
2022 · Zhao F., Sun B., Kobilka B.K., et al.
View Source ↗

Certificate of Analysis

Scroll to Top